BRD5080 is an effective positive allosteric modulator of GPR65, capable of inducing GPR65-dependent cAMP production. It demonstrates potent cAMP activity induction and G protein recruitment in both WT and mutant hGPR65, as well as its murine orthologs. With these capabilities, BRD5080 holds potential for use in research focused on autoimmune and inflammatory diseases.